NM_003001.5:c.78-1G>T
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_003001.5(SDHC):c.78-1G>T variant causes a splice acceptor, intron change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_003001.5 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDHC | NM_003001.5 | c.78-1G>T | splice_acceptor_variant, intron_variant | Intron 2 of 5 | ENST00000367975.7 | NP_002992.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Gastrointestinal stromal tumor;C1854336:Paragangliomas 3 Pathogenic:1
This sequence change affects an acceptor splice site in intron 2 of the SDHC gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SDHC-related conditions. ClinVar contains an entry for this variant (Variation ID: 534370). Studies have shown that disruption of this splice site results in skipping of skipping of exon 3, but is expected to preserve the integrity of the reading-frame (internal data). This variant disrupts a region of the SDHC protein in which other variant(s) (p.Arg50Cys) have been determined to be pathogenic (PMID: 19351833, 23175444, 23666964, 24102379). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.78-1G>T intronic variant results from a G to T substitution one nucleotide upstream from coding exon 3 of the SDHC gene. This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This nucleotide position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site. RNA studies have demonstrated that this alteration results in abnormal splicing in the set of samples tested (Ambry internal data). Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. As such, this alteration is classified as likely pathogenic. -
Hereditary pheochromocytoma-paraganglioma Pathogenic:1
This variant disrupts a canonical splice site and is predicted to result in abnormal splicing. Aberrant splicing and/or loss of function is an established disease mechanism. To date, this variant has not been reported in association with human disease in the medical literature. This variant is absent from large population databases, including the Genome Aggregation Database (http://gnomad.broadinstitute.org/). A different variant in this splice acceptor site (c.78-2A>G) has been previously reported in individuals with pheochromocytoma or paraganglioma (PMID: 18212813, 31666924). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at